Newco News Shanghai startup Eccogene bets on small molecules for NASH June 9, 2020 By Elise Mak No Comments BEIJING – After his role as associate director and head of chemistry at Eli Lilly and Co., Brandeis-trained Jingye Zhou founded Eccogene Inc. in Shanghai in 2018 to focus on developing small-molecule drugs for metabolism and immune-related diseases.Read More